ah 6809 has been researched along with Pelvic Pain in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arosh, JA; Balasubbramanian, D; Banu, SK; Bruner-Tran, KL; Burghardt, RC; Lee, J; Long, CR; Meagher, MW; Osteen, KG; Stanley, JA; Starzinski-Powitz, A | 1 |
1 other study(ies) available for ah 6809 and Pelvic Pain
Article | Year |
---|---|
Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.
Topics: Animals; Apoptosis; Biphenyl Compounds; Caspase 3; Cell Line; Cell Movement; Cell Survival; Disease Models, Animal; Endometriosis; Endometrium; Estrogens; Female; Humans; Inflammation; Mice; Neovascularization, Pathologic; Pelvic Pain; Poly(ADP-ribose) Polymerases; Progesterone; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Steroids; Xanthones | 2015 |